Cargando…
Drugs in development: bisphosphonates and metalloproteinase inhibitors
The destruction of bone and cartilage is characteristic of the progression of musculoskeletal diseases. The present review discusses the developments made with two different classes of drugs, the bisphosphonates and matrix metalloproteinase inhibitors. Bisphosphonates have proven to be an effective...
Autores principales: | Catterall, Jon B, Cawston, Tim E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154424/ https://www.ncbi.nlm.nih.gov/pubmed/12716443 http://dx.doi.org/10.1186/ar604 |
Ejemplares similares
-
Mechanisms of cartilage matrix turnover: synergistic interactions of proinflammatory cytokines with oncostatin M in upregulating matrix metalloproteinases and ADAMTS metalloproteinases
por: Cawston, TE, et al.
Publicado: (2005) -
Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis
por: Milner, Jennifer M, et al.
Publicado: (2006) -
The role of bisphosphonates in breast cancer: Development of bisphosphonates
por: Fleisch, Herbert
Publicado: (2002) -
Bisphosphonates as antimyeloma drugs
por: Modi, N D, et al.
Publicado: (2012) -
Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption
por: Young, David A, et al.
Publicado: (2005)